Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 14, 2023 08:30 ET | Source: Future Market Insights Global and Consulting Pvt. Ltd.

Global Yeast Infection Treatment Market Set to Surpass US$ 10031.3 Million by 2034, Forecasts Future Market Insights, Inc.

NEWARK, Del, Dec. 14, 2023 (GLOBE NEWSWIRE) -- According to Future Market Insights (FMI) latest industry analysis, the global yeast infection treatment market is expected to reach US$ 6479.8...
April 09, 2021 20:35 ET | Source: Marketing By Kevin

Keravita Pro Review: Negative Side Effects or Real Benefits?

San Francisco, CA, April 09, 2021 (GLOBE NEWSWIRE) -- Healthy nails are a good indicator of a healthy lifestyle. One needs to learn how to improve on the conditions of this essential organ of the...
August 08, 2019 16:07 ET | Source: Cidara Therapeutics, Inc.

Cidara Provides Corporate Update and Reports Second Quarter 2019 Financial Results

SAN DIEGO, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives, including immunotherapies, today reported financial...
March 29, 2017 07:30 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics to Host Investor Day on April 6, 2017

SAN DIEGO, March 29, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, will host an Investor Day...
May 12, 2016 17:12 ET | Source: Cidara Therapeutics, Inc.

Cidara Reports First Quarter 2016 Financial Results and Provides Corporate Update

SAN DIEGO, May 12, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
February 03, 2016 07:30 ET | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics Announces Participation in Leerink Partners 5th Annual Global Healthcare Conference

SAN DIEGO, Feb. 03, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...